Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Intravitreal Aflibercept on Ocular Perfusion - a Pilot Study

NCT03804099 is registered in ClinicalTrials.gov with Augenabteilung Allgemeines Krankenhaus Linz as lead sponsor.

NCT NCT03804099
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03804099 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Intravitreal Aflibercept on Ocular Perfusion - a Pilot Study
Lead sponsor
Augenabteilung Allgemeines Krankenhaus Linz
Phase
Phase 4
Overall status
Completed
Start date
March 1, 2017
Completion date
May 18, 2018
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anti vascular endothelial growth factor, macular degeneration